RecruitingNot ApplicableNCT05696652

Identifying Markers of Exercise Training in Heart Failure


Sponsor

Stanford University

Enrollment

90 participants

Start Date

Mar 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The heart failure syndrome that occurs when the heart is too sick to properly do its job. One of the main symptoms is difficulty with exercise. One way to improve symptoms is to start patients in a 12 week exercise program called cardiac rehabilitation. Cardiac rehabilitation been shown to improve symptoms for heart failure patients. However, the investigators do not know exactly what exercise does to the molecules that make up the human body. If the investigators could answer this question, the investigators might find a whole new way to treat the symptoms of heart failure. Therefore the investigators want to know what molecules might be responsible for the benefits of exercise. The plan for this study is to measure the levels of thousands of proteins in blood samples which come from people with heart failure and see how those levels change after 12 weeks of cardiac rehabilitation, compared to the protein levels in patients whose cardiac rehabilitation is delayed until after the study period. If the investigators know the proteins that change with exercise, the investigators can then look to see if targeting these proteins with medicines can mimic the benefits of exercise. The long term goal of our work is to identify "exercise-in-a-pill" medicines that will help people with heart failure.


Eligibility

Min Age: 18 YearsMax Age: 89 Years

Plain Language Summary

Simplified for easier understanding

This study looks for biological markers (measurable signals in the blood) that show how exercise training benefits people with heart failure — specifically those with reduced pumping ability (ejection fraction below 40%). The goal is to better understand why cardiac rehab works. **You may be eligible if...** - You are 18–89 years old with heart failure and an ejection fraction (heart pumping strength) below 40% - You are willing and able to participate in cardiac rehabilitation - You have not done cardiac rehab in the past year - You are able to walk on a treadmill **You may NOT be eligible if...** - You have had fainting during exercise testing or dangerous heart rhythm problems during exercise - Your BMI is 38 or higher - You have a bleeding disorder or active blood clot - You cannot safely complete the exercise tests Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAcute exercise

40 minute moderate intensity exercise bout on a treadmill. This is similar to a single session of cardiac rehabilitation.

BEHAVIORALCardiac rehabilitation

12 week program of standard clinical cardiac rehabilitation for patients with symptomatic heart failure. Patients undergo 3-times weekly sessions of monitored exercise for 12 weeks. This is the same cardiac rehabilitation patients would get as part of clinical care.


Locations(1)

Stanford Health Care

Stanford, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05696652


Related Trials